Dr. Cai’s research mainly focuses on enhancing the effectiveness of cardiac stem cell therapy for ischemic heart disease via genetic modification of protein coding or non-coding genes, or pharmaceutical administration with small molecules. His lab also investigates the role of long noncoding RNAs (lncRNAs) in the cardioprotection.


  • PhD: Institute of Biophysics, China, Molecular Biology & Biochemistry
  • Fellowship: UMDNJ-Robert Wood Johnson Medical School, U.S., Postdoctoral Fellow in Physiology & Biophysics

Research Interests

  • Ischemic heart disease
  • Myocardial repair/regeneration
  • Cardiac stem/progenitor cells
  • Aging/Senescence
  • Oxidative stress

Current Funding

  • NIH/NHLBI-1R01HL114951 
    “Enhancing the effectiveness of human cardiac stem cell therapy”